Cargando…

The impact of the SARS-CoV-2 pandemic on the prevalence of respiratory tract pathogens in patients with community-acquired pneumonia in Germany

We show a shift in the prevalence of respiratory viral pathogens in community-acquired pneumonia patients during the COVID-19 pandemic. Our data support the efficiency of non-pharmaceutical interventions on virus circulation except for rhinoviruses. The consequences of an altered circulation on subs...

Descripción completa

Detalles Bibliográficos
Autores principales: Dähne, Theo, Bauer, Wolfgang, Essig, Andreas, Schaaf, Bernhard, Spinner, Christoph D., Pletz, Mathias W., Rohde, Gernot, Rupp, Jan, Witzenrath, Martin, Panning, Marcus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8330739/
https://www.ncbi.nlm.nih.gov/pubmed/34269641
http://dx.doi.org/10.1080/22221751.2021.1957402
_version_ 1783732782463188992
author Dähne, Theo
Bauer, Wolfgang
Essig, Andreas
Schaaf, Bernhard
Spinner, Christoph D.
Pletz, Mathias W.
Rohde, Gernot
Rupp, Jan
Witzenrath, Martin
Panning, Marcus
author_facet Dähne, Theo
Bauer, Wolfgang
Essig, Andreas
Schaaf, Bernhard
Spinner, Christoph D.
Pletz, Mathias W.
Rohde, Gernot
Rupp, Jan
Witzenrath, Martin
Panning, Marcus
author_sort Dähne, Theo
collection PubMed
description We show a shift in the prevalence of respiratory viral pathogens in community-acquired pneumonia patients during the COVID-19 pandemic. Our data support the efficiency of non-pharmaceutical interventions on virus circulation except for rhinoviruses. The consequences of an altered circulation on subsequent winter seasons remain unclear and support the importance of systematic virological surveillance.
format Online
Article
Text
id pubmed-8330739
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Taylor & Francis
record_format MEDLINE/PubMed
spelling pubmed-83307392021-08-09 The impact of the SARS-CoV-2 pandemic on the prevalence of respiratory tract pathogens in patients with community-acquired pneumonia in Germany Dähne, Theo Bauer, Wolfgang Essig, Andreas Schaaf, Bernhard Spinner, Christoph D. Pletz, Mathias W. Rohde, Gernot Rupp, Jan Witzenrath, Martin Panning, Marcus Emerg Microbes Infect Letter We show a shift in the prevalence of respiratory viral pathogens in community-acquired pneumonia patients during the COVID-19 pandemic. Our data support the efficiency of non-pharmaceutical interventions on virus circulation except for rhinoviruses. The consequences of an altered circulation on subsequent winter seasons remain unclear and support the importance of systematic virological surveillance. Taylor & Francis 2021-08-01 /pmc/articles/PMC8330739/ /pubmed/34269641 http://dx.doi.org/10.1080/22221751.2021.1957402 Text en © 2021 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Letter
Dähne, Theo
Bauer, Wolfgang
Essig, Andreas
Schaaf, Bernhard
Spinner, Christoph D.
Pletz, Mathias W.
Rohde, Gernot
Rupp, Jan
Witzenrath, Martin
Panning, Marcus
The impact of the SARS-CoV-2 pandemic on the prevalence of respiratory tract pathogens in patients with community-acquired pneumonia in Germany
title The impact of the SARS-CoV-2 pandemic on the prevalence of respiratory tract pathogens in patients with community-acquired pneumonia in Germany
title_full The impact of the SARS-CoV-2 pandemic on the prevalence of respiratory tract pathogens in patients with community-acquired pneumonia in Germany
title_fullStr The impact of the SARS-CoV-2 pandemic on the prevalence of respiratory tract pathogens in patients with community-acquired pneumonia in Germany
title_full_unstemmed The impact of the SARS-CoV-2 pandemic on the prevalence of respiratory tract pathogens in patients with community-acquired pneumonia in Germany
title_short The impact of the SARS-CoV-2 pandemic on the prevalence of respiratory tract pathogens in patients with community-acquired pneumonia in Germany
title_sort impact of the sars-cov-2 pandemic on the prevalence of respiratory tract pathogens in patients with community-acquired pneumonia in germany
topic Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8330739/
https://www.ncbi.nlm.nih.gov/pubmed/34269641
http://dx.doi.org/10.1080/22221751.2021.1957402
work_keys_str_mv AT dahnetheo theimpactofthesarscov2pandemicontheprevalenceofrespiratorytractpathogensinpatientswithcommunityacquiredpneumoniaingermany
AT bauerwolfgang theimpactofthesarscov2pandemicontheprevalenceofrespiratorytractpathogensinpatientswithcommunityacquiredpneumoniaingermany
AT essigandreas theimpactofthesarscov2pandemicontheprevalenceofrespiratorytractpathogensinpatientswithcommunityacquiredpneumoniaingermany
AT schaafbernhard theimpactofthesarscov2pandemicontheprevalenceofrespiratorytractpathogensinpatientswithcommunityacquiredpneumoniaingermany
AT spinnerchristophd theimpactofthesarscov2pandemicontheprevalenceofrespiratorytractpathogensinpatientswithcommunityacquiredpneumoniaingermany
AT pletzmathiasw theimpactofthesarscov2pandemicontheprevalenceofrespiratorytractpathogensinpatientswithcommunityacquiredpneumoniaingermany
AT rohdegernot theimpactofthesarscov2pandemicontheprevalenceofrespiratorytractpathogensinpatientswithcommunityacquiredpneumoniaingermany
AT ruppjan theimpactofthesarscov2pandemicontheprevalenceofrespiratorytractpathogensinpatientswithcommunityacquiredpneumoniaingermany
AT witzenrathmartin theimpactofthesarscov2pandemicontheprevalenceofrespiratorytractpathogensinpatientswithcommunityacquiredpneumoniaingermany
AT panningmarcus theimpactofthesarscov2pandemicontheprevalenceofrespiratorytractpathogensinpatientswithcommunityacquiredpneumoniaingermany
AT theimpactofthesarscov2pandemicontheprevalenceofrespiratorytractpathogensinpatientswithcommunityacquiredpneumoniaingermany
AT dahnetheo impactofthesarscov2pandemicontheprevalenceofrespiratorytractpathogensinpatientswithcommunityacquiredpneumoniaingermany
AT bauerwolfgang impactofthesarscov2pandemicontheprevalenceofrespiratorytractpathogensinpatientswithcommunityacquiredpneumoniaingermany
AT essigandreas impactofthesarscov2pandemicontheprevalenceofrespiratorytractpathogensinpatientswithcommunityacquiredpneumoniaingermany
AT schaafbernhard impactofthesarscov2pandemicontheprevalenceofrespiratorytractpathogensinpatientswithcommunityacquiredpneumoniaingermany
AT spinnerchristophd impactofthesarscov2pandemicontheprevalenceofrespiratorytractpathogensinpatientswithcommunityacquiredpneumoniaingermany
AT pletzmathiasw impactofthesarscov2pandemicontheprevalenceofrespiratorytractpathogensinpatientswithcommunityacquiredpneumoniaingermany
AT rohdegernot impactofthesarscov2pandemicontheprevalenceofrespiratorytractpathogensinpatientswithcommunityacquiredpneumoniaingermany
AT ruppjan impactofthesarscov2pandemicontheprevalenceofrespiratorytractpathogensinpatientswithcommunityacquiredpneumoniaingermany
AT witzenrathmartin impactofthesarscov2pandemicontheprevalenceofrespiratorytractpathogensinpatientswithcommunityacquiredpneumoniaingermany
AT panningmarcus impactofthesarscov2pandemicontheprevalenceofrespiratorytractpathogensinpatientswithcommunityacquiredpneumoniaingermany
AT impactofthesarscov2pandemicontheprevalenceofrespiratorytractpathogensinpatientswithcommunityacquiredpneumoniaingermany